A detailed history of Bamco Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Bamco Inc holds 33,995 shares of NVO stock, worth $3.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,995
Previous 45,982 26.07%
Holding current value
$3.52 Million
Previous $6.56 Million 38.34%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $1.43 Million - $1.74 Million
-11,987 Reduced 26.07%
33,995 $4.05 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $760,188 - $910,107
-6,195 Reduced 11.87%
45,982 $6.56 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $313,477 - $417,274
-3,070 Reduced 5.56%
52,177 $6.7 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $4.85 Million - $5.83 Million
55,247 New
55,247 $5.72 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $5.48 Million - $6.47 Million
53,100 New
53,100 $5.92 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.